Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tatsuki Fukami

Showing results (131-140 of 177) with videos related to

Pageof 18
Sort By:
Journal of Applied Toxicology : JAT|March 13, 2012
Th2 cytokine-mediated methimazole-induced acute liver injury in miceMasanori Kobayashi, Satonori Higuchi, Mika Ide, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 14, 2012
Metabolic activation and inflammation reactions involved in carbamazepine-induced liver injurySatonori Higuchi, Azusa Yano, Shohei Takai, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 23, 2015
Single-Nucleotide Polymorphisms in Cytochrome P450 2E1 (CYP2E1) 3'-Untranslated Region Affect the Regulation of CYP2E1 by miR-570Masataka Nakano, Takuya Mohri, Tatsuki Fukami, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 19, 2005
Characterization of novel CYP2A6 polymorphic alleles (CYP2A6*18 and CYP2A6*19) that affect enzymatic activityTatsuki Fukami, Miki Nakajima, Eriko Higashi, et al.
Biochemical Pharmacology|March 10, 2018
Identification of enzymes responsible for dantrolene metabolism in the human liver: A clue to uncover the cause of liver injuryTakayuki Amano, Tatsuki Fukami, Takuo Ogiso, et al.
Drug Metabolism and Pharmacokinetics|June 25, 2021
Epicatechin gallate and epigallocatechin gallate are potent inhibitors of human arylacetamide deacetylaseKaori Yasuda, Kazuki Watanabe, Tatsuki Fukami, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 8, 2026
CYP1A2 and ADH1C contribute to abacavir aldehyde intermediate formation in the human liverRei Sato, Masataka Nakano, Yuichiro Higuchi, et al.
Biochemical Pharmacology|October 30, 2020
Identification of an isoform catalyzing the CoA conjugation of nonsteroidal anti-inflammatory drugs and the evaluation of the expression levels of acyl-CoA synthetases in the human liverHiroki Hashizume, Tatsuki Fukami, Kanji Mishima, et al.
Journal of Clinical Pharmacology|February 24, 2006
Isoflavones inhibit nicotine C-oxidation catalyzed by human CYP2A6Miki Nakajima, Masahiro Itoh, Hiroyuki Yamanaka, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|December 14, 2011
Mechanism of exacerbative effect of progesterone on drug-induced liver injuryYasuyuki Toyoda, Shinya Endo, Koichi Tsuneyama, et al.
Pageof 18

Showing results (131-140 of 177) with videos related to

Sort By:
Pageof 18
Journal of Applied Toxicology : JAT|March 13, 2012
Th2 cytokine-mediated methimazole-induced acute liver injury in miceMasanori Kobayashi, Satonori Higuchi, Mika Ide, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 14, 2012
Metabolic activation and inflammation reactions involved in carbamazepine-induced liver injurySatonori Higuchi, Azusa Yano, Shohei Takai, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 23, 2015
Single-Nucleotide Polymorphisms in Cytochrome P450 2E1 (CYP2E1) 3'-Untranslated Region Affect the Regulation of CYP2E1 by miR-570Masataka Nakano, Takuya Mohri, Tatsuki Fukami, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 19, 2005
Characterization of novel CYP2A6 polymorphic alleles (CYP2A6*18 and CYP2A6*19) that affect enzymatic activityTatsuki Fukami, Miki Nakajima, Eriko Higashi, et al.
Biochemical Pharmacology|March 10, 2018
Identification of enzymes responsible for dantrolene metabolism in the human liver: A clue to uncover the cause of liver injuryTakayuki Amano, Tatsuki Fukami, Takuo Ogiso, et al.
Drug Metabolism and Pharmacokinetics|June 25, 2021
Epicatechin gallate and epigallocatechin gallate are potent inhibitors of human arylacetamide deacetylaseKaori Yasuda, Kazuki Watanabe, Tatsuki Fukami, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 8, 2026
CYP1A2 and ADH1C contribute to abacavir aldehyde intermediate formation in the human liverRei Sato, Masataka Nakano, Yuichiro Higuchi, et al.
Biochemical Pharmacology|October 30, 2020
Identification of an isoform catalyzing the CoA conjugation of nonsteroidal anti-inflammatory drugs and the evaluation of the expression levels of acyl-CoA synthetases in the human liverHiroki Hashizume, Tatsuki Fukami, Kanji Mishima, et al.
Journal of Clinical Pharmacology|February 24, 2006
Isoflavones inhibit nicotine C-oxidation catalyzed by human CYP2A6Miki Nakajima, Masahiro Itoh, Hiroyuki Yamanaka, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|December 14, 2011
Mechanism of exacerbative effect of progesterone on drug-induced liver injuryYasuyuki Toyoda, Shinya Endo, Koichi Tsuneyama, et al.
Pageof 18